Manage JCO Email Alerts

JCO RSS Feed

Vol. 21, No. 12, June 15, 2003

EDITORIALS

Gefitinib in Recurrent Non–Small-Cell Lung Cancer: An IDEAL Trial?
Johnson et al.
pp. 2227–2229
Citation | Full Text | PDF (33 KB) 
Gene Therapy: The Challenges of Translating Laboratory Research Into Clinical Practice
Connell et al.
pp. 2230–2231
Citation | Full Text | PDF (24 KB) 
The Surveillance, Epidemiology, and End-Results Program Database as a Resource for Conducting Descriptive Epidemiologic and Clinical Studies
Harlan et al.
pp. 2232–2233
Citation | Full Text | PDF (23 KB) 
The Gastric Cancer Treatment Controversy
van de Velde et al.
pp. 2234–2236
Citation | Full Text | PDF (30 KB) 

Original Reports

Lung Cancer

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
Fukuoka et al.
pp. 2237–2246
Abstract | Full Text | PDF (283 KB) 
Related Content

Errata

Phase I and Clinical Pharmacology

Repeated Intravesical Instillations of an Adenoviral Vector in Patients With Locally Advanced Bladder Cancer: A Phase I Study of p53 Gene Therapy
Pagliaro et al.
pp. 2247–2253
Abstract | Full Text | PDF (787 KB) 

Breast Cancer

Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities?
Anderson et al.
pp. 2254–2259
Abstract | Full Text | PDF (143 KB) 

Breast Cancer

Radiation Therapy Plus Tamoxifen Versus Tamoxifen Alone After Breast-Conserving Surgery in Postmenopausal Women With Stage I Breast Cancer: A Decision Analysis
Punglia et al.
pp. 2260–2267
Abstract | Full Text | PDF (1036 KB) 

Breast Cancer

Barriers to Clinical Trial Participation by Older Women With Breast Cancer
Kemeny et al.
pp. 2268–2275
Abstract | Full Text | PDF (132 KB) 
Related Content

Errata

Breast Cancer

Randomized Trial of 2 Versus 5 Years of Adjuvant Tamoxifen for Women Aged 50 Years or Older With Early Breast Cancer: Italian Interdisciplinary Group for Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01
Sacco et al.
pp. 2276–2281
Abstract | Full Text | PDF (105 KB) 

Gastrointestinal Cancer

Randomized Trial of Adjuvant Chemotherapy With Mitomycin, Fluorouracil, and Cytosine Arabinoside Followed by Oral Fluorouracil in Serosa-Negative Gastric Cancer: Japan Clinical Oncology Group 9206–1
Nashimoto et al.
pp. 2282–2287
Abstract | Full Text | PDF (294 KB) 

Gastrointestinal Cancer

Soluble E-Cadherin is an Independent Pretherapeutic Factor for Long-Term Survival in Gastric Cancer
Chan et al.
pp. 2288–2293
Abstract | Full Text | PDF (449 KB) 

Gastrointestinal Cancer

Simple Clinical Prognostic Model for Hepatocellular Carcinoma in Developing Countries and Its Validation
Tan et al.
pp. 2294–2298
Abstract | Full Text | PDF (109 KB) 

Central Nervous System

Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas
Fine et al.
pp. 2299–2304
Abstract | Full Text | PDF (1529 KB) 

Central Nervous System

Phase II Evaluation of Temozolomide and 13-cis-Retinoic Acid for the Treatment of Recurrent and Progressive Malignant Glioma: A North American Brain Tumor Consortium Study
Jaeckle et al.
pp. 2305–2311
Abstract | Full Text | PDF (91 KB) 

Genitourinary Cancer

Single Nucleotide Polymorphism of the Human Kallikrein-2 Gene Highly Correlates With Serum Human Kallikrein-2 Levels and in Combination Enhances Prostate Cancer Detection
Nam et al.
pp. 2312–2319
Abstract | Full Text | PDF (79 KB) 

Hematologic Malignancies

High-Dose Therapy and Autologous Stem-Cell Transplantation Versus Conventional Therapy for Patients With Advanced Hodgkin’s Lymphoma Responding to Front-Line Therapy
Federico et al.
pp. 2320–2325
Abstract | Full Text | PDF (195 KB) 

Hematologic Malignancies

Combined Treatment With Arsenic Trioxide and All-Trans-Retinoic Acid in Patients With Relapsed Acute Promyelocytic Leukemia
Raffoux et al.
pp. 2326–2334
Abstract | Full Text | PDF (419 KB) 

Hematologic Malignancies

Presentation Serum Selenium Predicts for Overall Survival, Dose Delivery, and First Treatment Response in Aggressive Non-Hodgkin’s Lymphoma
Last et al.
pp. 2335–2341
Abstract | Full Text | PDF (96 KB) 

Melanoma

Immunization With Melan-A Peptide-Pulsed Peripheral Blood Mononuclear Cells Plus Recombinant Human Interleukin-12 Induces Clinical Activity and T-Cell Responses in Advanced Melanoma
Peterson et al.
pp. 2342–2348
Abstract | Full Text | PDF (211 KB) 

Pediatric Oncology

Long-Term Prospective Follow-Up Study of Cardiac Function After Cardiotoxic Therapy for Malignancy in Children
Poutanen et al.
pp. 2349–2356
Abstract | Full Text | PDF (603 KB) 

Pediatric Oncology

Ovarian Sex Cord–Stromal Tumors in Children and Adolescents
Schneider et al.
pp. 2357–2363
Abstract | Full Text | PDF (89 KB) 
Related Content

ERRATUM

Radiation Oncology

RSR13 Plus Cranial Radiation Therapy in Patients With Brain Metastases: Comparison With the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database
Shaw et al.
pp. 2364–2371
Abstract | Full Text | PDF (277 KB) 

Supportive Care and Quality of Life

Inhalation Aromatherapy During Radiotherapy: Results of a Placebo-Controlled Double-Blind Randomized Trial
Graham et al.
pp. 2372–2376
Abstract | Full Text | PDF (57 KB) 

ASCO SPECIAL ARTICLES

American Society of Clinical Oncology Policy Statement: Oversight of Clinical Research
pp. 2377–2386
Abstract | Full Text | PDF (77 KB) 
American Society of Clinical Oncology: Background for Update of Conflict of Interest Policy
pp. 2387–2393
Citation | Full Text | PDF (50 KB) 
American Society of Clinical Oncology: Revised Conflict of Interest Policy
pp. 2394–2396
Citation | Full Text | PDF (27 KB) 
American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility
pp. 2397–2406
Abstract | Full Text | PDF (89 KB) 

SPECIAL ARTICLES

Summary Statement on Primary Central Nervous System Lymphomas From the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002
Ferreri et al.
pp. 2407–2414
Abstract | Full Text | PDF (130 KB) 

BIOLOGY OF NEOPLASIA

Current Developments in Cancer Vaccines and Cellular Immunotherapy
Ribas et al.
pp. 2415–2432
Abstract | Full Text | PDF (1020 KB) 

ART OF ONCOLOGY

Teaching Communication Skills to Medical Oncology Fellows
Back et al.
pp. 2433–2436
Citation | Full Text | PDF (38 KB) 

DIAGNOSIS IN ONCOLOGY

Small-Cell Cancers, and an Unusual Reaction to Chemotherapy
Brown et al.
pp. 2437–2438
Citation | Full Text | PDF (2604 KB) 
Small-Cell Cancers, and an Unusual Reaction to Chemotherapy
Massarweh et al.
pp. 2439–2440
Citation | Full Text | PDF (2604 KB) 
Small-Cell Cancers, and an Unusual Reaction to Chemotherapy
Chaudhary et al.
pp. 2441–2442
Citation | Full Text | PDF (2604 KB) 
Small-Cell Cancers, and an Unusual Reaction to Chemotherapy
Bucaloiu et al.
pp. 2442–2443
Citation | Full Text | PDF (2604 KB) 

CORRESPONDENCE

Free Access
Paradigm Shift in Adjuvant Treatment of Receptor Positive Premenopausal Breast Cancer Patients? Not Yet!
Samur et al.
pp. 2444
Citation | Full Text | PDF (52 KB) 
Free Access
Can Endocrine Treatment for Hormone-Positive Premenopausal Women With Early Breast Cancer Replace Adjuvant Chemotherapy?
Malayeri
pp. 2444–2445
Citation | Full Text | PDF (52 KB) 
Free Access
Combined Endocrine Blockade in Premenopausal Breast Cancer: A Superior Therapeutic Option for Adjuvant Management?
Kohli et al.
pp. 2445
Citation | Full Text | PDF (52 KB) 
Free Access
pp. 2445–2446
Citation | Full Text | PDF (52 KB) 
Free Access
pp. 2446
Citation | Full Text | PDF (52 KB) 
Free Access
pp. 2446–2447
Citation | Full Text | PDF (52 KB) 
Free Access
Correction to “Congestive Heart Failure After Treatment for Wilms’ Tumor”
Green et al.
pp. 2447–2448
Citation | Full Text | PDF (52 KB) 

ERRATA

Erratum
pp. 2449
Citation | Full Text | PDF (7 KB) 
Related Content

ORIGINAL REPORTS

Publication Cover

ASCO Career Center